MedPath

PHENOBARBITAL SODIUM INJECTION, USP

PHENOBARBITAL SODIUM INJECTION, USP

Approved
DIN Number

02304090

Drug Class

Human

Market Date

Feb 29, 2008

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02304090
AIG Number0105985001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
N03AA02 PHENOBARBITAL
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification28:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

PHENOBARBITAL SODIUMActive
Strength: 120 MG / ML
Monograph: PHENOBARBITAL SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.